Geneos Wealth Management’s Pacific Biosciences PACB Stock Holding History

Geneos Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-240	Closed	-$1K	–	2424
2022 Q2	$1K	Hold	240	–	–	﹤0.01%	2523
2022 Q1	$2K	Hold	240	–	–	﹤0.01%	2562
2021 Q4	$4K	Hold	240	–	–	﹤0.01%	2472
2021 Q3	$6K	Hold	240	–	–	﹤0.01%	2403
2021 Q2	$8K	Hold	240	–	–	﹤0.01%	2289
2021 Q1	$7K	Hold	240	–	–	﹤0.01%	2542
2020 Q4	$7K	Buy	+240	New	+$4.08K	﹤0.01%	2374
2019 Q4	–	Sell	-5,600	Closed	-$29K	–	2569
2019 Q3	$29K	Hold	5,600	–	–	﹤0.01%	1444
2019 Q2	$33K	Hold	5,600	–	–	﹤0.01%	1396
2019 Q1	$40K	Sell	5,600 -8,000	-59%	-$57.9K	﹤0.01%	1249
2018 Q4	$99K	Hold	13,600	–	–	0.01%	836
2018 Q3	$73K	Hold	13,600	–	–	﹤0.01%	1002
2018 Q2	$48K	Hold	13,600	–	–	﹤0.01%	1071
2018 Q1	$27K	Hold	13,600	–	–	﹤0.01%	1260
2017 Q4	$35K	Buy	13,600 +8,750	+180%	+$30.6K	﹤0.01%	1163
2017 Q3	$25K	Hold	4,850	–	–	﹤0.01%	1245
2017 Q2	$17K	Hold	4,850	–	–	﹤0.01%	1340
2017 Q1	$25K	Buy	4,850 +750	+18%	+$3.67K	﹤0.01%	1162
2016 Q4	$15K	Buy	+4,100	New	+$29.8K	﹤0.01%	1300

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geneos Wealth Management's PACB Position: Q3 2022 in Review

Geneos Wealth Management sold out of Pacific Biosciences (PACB) in Q3 2022, closing a stake of 240 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in PACB in Q4 2016 and held it in 19 quarters. The position peaked at $99K in Q4 2018. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2022.

Geneos Wealth Management reported no remaining Pacific Biosciences position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 240 Pacific Biosciences shares in Q3 2022, an estimated $1K.
Geneos Wealth Management first reported a position in Pacific Biosciences in Q4 2016 and held it in 19 quarters.
Geneos Wealth Management's Pacific Biosciences position peaked at $99K in Q4 2018.
226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.